Relatlimab, an Immune Checkpoint Inhibitor that Blocks LAG-3, the Latest Drug to be Added to the Arsenal of Systemic Therapies for Melanoma: What Does a Surgical Oncologist Need to Know? Alexander C. J. van Akkooi ASO Perspectives 16 October 2023 Pages: 1 - 3
Neoadjuvant and Adjuvant Pembrolizumab for the Treatment of Early-Stage Resectable Non-small Cell Lung Cancer An Editorial Regarding the Interim Data Analysis of the KEYNOTE-671 Phase III Trial of Neoadjuvant and Adjuvant Pembrolizumab Jessica M. RuckStephen R. Broderick ASO Perspectives 26 October 2023 Pages: 4 - 5
Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6 Katryna K. ThomasAmanda B. FrancescattiAnthony M. Villano Colorectal Cancer 26 October 2023 Pages: 6 - 9
The Critical Evolution of the Concept of Frailty in Surgery Georgios Tsoulfas Global Health Services Research 05 November 2023 Pages: 10 - 11
Best Practices for Handling Missing Data Shukla SrijanIyer R. Rajagopalan Global Health Services Research 22 October 2023 Pages: 12 - 13
Circulating Tumor Cells are an Independent Risk Factor for Poor Prognosis in Gallbladder Adenocarcinoma Patients N. DevaudF. Aucejo Hepatobiliary Tumors 03 October 2023 Pages: 14 - 15
Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis Anastasios KarnerisAikaterini DedeiliaGenevieve M. Boland Hepatobiliary Tumors 09 October 2023 Pages: 16 - 18
Adjuvant Hepatic Artery Infusion Chemotherapy: Still Swimming in Dark Water? Alejandro BrañesPaul Karanicolas Hepatobiliary Tumors 13 October 2023 Pages: 19 - 20
Customizing Therapy for Esophageal Cancer: CROSS vs. FLOT Sadia TasnimMonisha Sudarshan Thoracic Oncology 13 October 2023 Pages: 21 - 22
Major Intraoperative Complications during Minimally Invasive Esophagectomy: Experience is a Hard Teacher Jonathan C. Salo Thoracic Oncology 29 October 2023 Pages: 23 - 24
Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis? Gavitt A. WoodardChristina ChoLieping Chen Translational Research 29 October 2023 Pages: 25 - 27
Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer with Peritoneal Dissemination (PERISCOPE II) Amber Leila SarvestaniStephanie N. GregoryJohanna W. van Sandick ASO Research Letter 10 November 2023 Pages: 28 - 30
Perceptions of Readiness for Practice After Complex General Surgical Oncology Fellowship: A Survey Study Shay BehrensHeather A. LillemoeJeremy L. Davis Global Health Services Research Open access 07 November 2023 Pages: 31 - 41
Addressing Data Aggregation and Data Inequity in Race and Ethnicity Reporting and the Impact on Breast Cancer Disparities Brianna WilsonJane MendezKathie-Ann Joseph Global Health Services Research 15 October 2023 Pages: 42 - 48
Poor Access to Mental Healthcare is Associated with Worse Postoperative Outcomes Among Patients with Gastrointestinal Cancer Erryk S. KatayamaSelamawit WoldesenbetTimothy M. Pawlik Global Health Services Research 09 October 2023 Pages: 49 - 57
Treatment Patterns and Outcomes in Pancreatic Cancer: A Comparative Analysis of Ontario and the USA Lily V. SaadatElizabeth SchofieldAlice C. Wei Global Health Services Research 13 October 2023 Pages: 58 - 65
ASO Author Reflections: Major Abdominal Surgery in Elderly Cancer Patients Marion FaucherDjamel Mokart ASO Author Reflections 01 November 2023 Pages: 66 - 66
ASO Visual Abstract: Factors Associated with 1-Year Mortality of Elderly Patients (Age 80 Years and Older) with Cancer Undergoing Major Abdominal Surgery: A Retrospective Cohort Study Julie CanacMarion FaucherDjamel Mokart ASO Visual Abstract 31 October 2023 Pages: 67 - 68
ASO Author Reflections: Access to Mental Healthcare and Outcomes in Gastrointestinal Cancer Surgery Erryk S. KatayamaTimothy M. Pawlik ASO Author Reflections 13 October 2023 Pages: 69 - 70
ASO Visual Abstract: Poor Access to Mental Healthcare is Associated with Worse Postoperative Outcomes among Patients with Gastrointestinal Cancer Erryk S. KatayamaSelamawit WoldesenbetTimothy M. Pawlik ASO Visual Abstract 18 October 2023 Pages: 71 - 71
ASO Visual Abstract: Standardization of Colon Resection for Cancer—An Overview of the American College of Surgeons Commission on Cancer Standard 5.6 Katryna K. ThomasAmanda B. FrancescattiAnthony M. Villano ASO Visual Abstract 01 November 2023 Pages: 72 - 73
ASO Author Reflections: The Impact of Tumor Deposits on Survival of Patients with Stage III Colorectal Cancer Xuzhi ZhengLechi Ye ASO Author Reflections 15 October 2023 Pages: 74 - 74
Top Hepatobiliary Articles from 2022 to Inform Your Cancer Practice Zachary J. BrownTimothy M. Pawlik Hepatobiliary Tumors 16 October 2023 Pages: 75 - 80
Clinical Outcomes of Robotic Resection for Perihilar Cholangiocarcinoma: A First, Multicenter, Trans-Atlantic, Expert-Center, Collaborative Study Iswanto SucandyHugo P. MarquesFabrizio DiBenedetto Hepatobiliary Tumors 18 September 2023 Pages: 81 - 89
The Short- and Long-Term Surgical Results of Consecutive Hepatopancreaticoduodenectomy for Wide-Spread Biliary Malignancy Yasunori YoshimiTakehiro NojiSatoshi Hirano Hepatobiliary Tumors 29 October 2023 Pages: 90 - 96
Impact of Liver Cirrhosis, Severity of Cirrhosis, and Portal Hypertension on the Difficulty and Outcomes of Laparoscopic and Robotic Major Liver Resections for Primary Liver Malignancies Federica CiprianiLuca AldrighettiInternational Robotic and Laparoscopic Liver Resection Study Group Investigators Hepatobiliary Tumors 07 November 2023 Pages: 97 - 114
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma Stijn FranssenJessica J. HolsterBas Groot Koerkamp Hepatobiliary Tumors Open access 09 October 2023 Pages: 115 - 124
Prognostic Significance of Tumor Necrosis in Patients with Gallbladder Carcinoma Undergoing Curative-Intent Resection Si-qi YangJun-ke WangHai-jie Hu Hepatobiliary Tumors 26 October 2023 Pages: 125 - 132
The Influence of Hepatic Steatosis and Fibrosis on Postoperative Outcomes After Major Liver Resection of Perihilar Cholangiocarcinoma Anne-Marleen van KeulenPim B. OlthofMichail Doukas Hepatobiliary Tumors Open access 29 October 2023 Pages: 133 - 141
Conditional Overall Survival After Diagnosis of Non-Metastatic Colon Cancer: Impact of Laterality, MSI, and KRAS Status Catherine G. TranPaolo GoffredoImran Hassan Hepatobiliary Tumors 19 October 2023 Pages: 142 - 151
ASO Author Reflections: Tumor Necrosis—A Poor Prognostic Factor of Gallbladder Carcinoma Rui-Qi ZouSi-Qi YangFu-Yu Li ASO Author Reflections 06 November 2023 Pages: 152 - 153
ASO Author Reflections: Clinical Outcomes of Robotic Resection for Perihilar Cholangiocarcinoma: A First Multicenter, Trans-Atlantic, Expert-Center Collaborative Study Iswanto SucandyHugo P. MarquesFabrizio DiBenedetto ASO Author Reflections 29 September 2023 Pages: 154 - 155
ASO Author Reflections: Optimizing Treatment Sequencing in Synchronous Resectable Colorectal Liver Metastases Joy SarkarRoderich E. Schwarz ASO Author Reflections 18 October 2023 Pages: 156 - 157
ASO Visual Abstract: Perioperative Chemotherapy is Associated with Superior Overall Survival in Patients with Synchronous Colorectal Liver Metastases Joy SarkarKristopher AttwoodRoderich E. Schwarz ASO Visual Abstract 31 October 2023 Pages: 158 - 158
ASO Visual Abstract: Extended Right Hepatectomy to Inferior Vena Cava Under Total Vascular Exclusion, Veno-Venous Bypass and In Situ Hypothermic Perfusion of the Future Liver Remnant Pierre de MathelinCaterina CusumanoPietro Addeo ASO Visual Abstract 28 September 2023 Pages: 159 - 160
ASO Visual Abstract: Clinical Outcomes of Robotic Resection for Perihilar Cholangiocarcinoma: A First Multicenter Trans-Atlantic Expert Center Collaborative Study Iswanto SucandyHugo P. MarquesFabrizio DiBenedetto ASO Visual Abstract 09 October 2023 Pages: 161 - 162
Circulating Tumor DNA Dynamics: A New Approach in Revolutionizing Cancer Management Adwaith Krishna SurendranParit T. MavaniChellappa Vijayakumar Hepatobiliary Tumors 14 October 2023 Pages: 163 - 164
Reply to “Circulating Tumor DNA Dynamics: A New Approach in Revolutionising Cancer Management,” by Mavani, Parit et al. Xiang-Yu WangJin-Hong Chen Hepatobiliary Tumors 29 October 2023 Pages: 165 - 166
Clinicopathologic Features and Survival Outcomes of Primary Lung Mucinous Adenocarcinoma Based on Different Radiologic Subtypes Wei LiYingying YangJingyun Shi Thoracic Oncology 05 November 2023 Pages: 167 - 177
Development and Validation of a Recurrence-Free Survival Prediction Model for Locally Advanced Esophageal Squamous Cell Carcinoma with Neoadjuvant Chemoradiotherapy Yehan ZhouWenwu HeYang Liu Thoracic Oncology Open access 26 September 2023 Pages: 178 - 191
Impact of 18F-FDG PET on TNM Staging and Prognosis in Thymic Epithelial Tumors Takaki AkamineKazuo NakagawaShun-ichi Watanabe Thoracic Oncology 25 September 2023 Pages: 192 - 200
Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread Dong Woog YoonSoohyun HwangJong Ho Cho Thoracic Oncology 09 October 2023 Pages: 201 - 212
Impact of Surveillance Imaging in Detecting Local and Metastatic Lung Recurrences Among Patients with Sarcomas of the Extremities: A Systematic Review and Meta-analysis Shyam SrinivasanSwaminathan KeerthivasagamAjay Puri Thoracic Oncology 22 October 2023 Pages: 213 - 227
The Effect of Neoadjuvant Therapy on Esophagectomy for cT2N0M0 Esophageal Adenocarcinoma Jorge Humberto Rodriguez-QuinteroMohamed K. KamelBrendon M. Stiles Thoracic Oncology 26 October 2023 Pages: 228 - 238
ASO Author Reflections: Prognosis of Esophageal Cancer After Neoadjuvant Therapy: A More Accurate Evaluation System is Needed Yehan ZhouZongyao HuangYang Liu ASO Author Reflections 30 September 2023 Pages: 239 - 240
ASO Author Reflections: A Novel, Sensitive, and Effective Index in Predicting Therapeutic Response of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma Jifeng FengLiang WangXiangdong Cheng ASO Author Reflections 14 October 2023 Pages: 241 - 242
ASO Author Reflections: Prognostic Significance of Kallikrein-Related Peptidase 13 Induction After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma Akira ShimomuraKazuhiko YamadaYuki I. Kawamura ASO Author Reflections 18 October 2023 Pages: 243 - 244
ASO Visual Abstract: Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules—A Large Study of 2022 Cases in China Xiongwen YangYi XiaoWen-Zhao Zhong ASO Visual Abstract 16 October 2023 Pages: 245 - 246
ASO Visual Abstract: Characteristics Predicting Short-Term and Long-Term, Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and Esophagectomy Berend J. van der WilkBen M. EyckJ. Jan B. van Lanschot ASO Visual Abstract 16 October 2023 Pages: 247 - 248
ASO Visual Abstract: Induction of Kallikrein-Related Peptidase 13 and TET2/3 by Anticancer Drugs and the Poor Prognosis for Patients with Esophageal Squamous Cell Carcinoma After Preoperative Treatment Akira ShimomuraTeruki HagiwaraYuki I. Kawamura ASO Visual Abstract 22 October 2023 Pages: 249 - 250